Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is poised to achieve substantial growth with its integrated, end-to-end medical imaging and healthcare services platform, as indicated by its recent channel partnerships with Howard Technology Solutions, Digital X-Ray Imaging, and Imperial Imaging Technology, showcasing the company's progress in expanding its market reach and driving adoption. However, the company's financial position may hinder its ability to fully execute on its growth plans, highlighting the need for additional funding. Factors such as clinical/regulatory, financial, and commercial risks must be carefully managed, but upcoming catalysts such as further distribution agreements and initial system deployments show potential for significant revenue growth in the future.

Bears say

Nano X Imaging is experiencing financial difficulties as evidenced by its increasing net losses, primarily due to an impairment charge related to its South Korean chip manufacturing line. The company's key revenue driver is its Radiology Services segment, which generated only $3.1M in revenue in the last reporting period. While the company has ambitious plans for growth, the success of these plans is uncertain and highly dependent on various factors such as system placements, utilization rates, and reimbursement dynamics.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.